DK1529040T3 - Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma - Google Patents

Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma

Info

Publication number
DK1529040T3
DK1529040T3 DK03784025T DK03784025T DK1529040T3 DK 1529040 T3 DK1529040 T3 DK 1529040T3 DK 03784025 T DK03784025 T DK 03784025T DK 03784025 T DK03784025 T DK 03784025T DK 1529040 T3 DK1529040 T3 DK 1529040T3
Authority
DK
Denmark
Prior art keywords
derivatives
optionally substituted
use against
against asthma
alkenyloxy
Prior art date
Application number
DK03784025T
Other languages
Danish (da)
English (en)
Inventor
Claudia Eder
Herbert Kogler
Sabine Haag-Richter
Robert Walker Singleton
Arun Subramaniam
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1529040T3 publication Critical patent/DK1529040T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK03784025T 2002-08-02 2003-07-18 Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma DK1529040T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10235624A DE10235624A1 (de) 2002-08-02 2002-08-02 Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DK1529040T3 true DK1529040T3 (da) 2006-05-08

Family

ID=30469404

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784025T DK1529040T3 (da) 2002-08-02 2003-07-18 Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma

Country Status (13)

Country Link
US (1) US7019028B2 (https=)
EP (1) EP1529040B1 (https=)
JP (1) JP4598523B2 (https=)
AT (1) ATE314359T1 (https=)
AU (1) AU2003250099B2 (https=)
BR (1) BR0313199A (https=)
CA (1) CA2493483C (https=)
DE (2) DE10235624A1 (https=)
DK (1) DK1529040T3 (https=)
ES (1) ES2254980T3 (https=)
IL (1) IL166439A (https=)
MX (1) MXPA05000387A (https=)
WO (1) WO2004014888A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
CN108192972B (zh) 2010-10-06 2022-09-09 生物医学研究机构基金会 用于乳腺癌转移的诊断、预后和治疗的方法
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
BR112014030750A2 (pt) 2012-06-06 2017-08-22 Inst Catalana Recerca Estudis Avancats Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
ES2906586T3 (es) 2012-10-12 2022-04-19 Inbiomotion Sl Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata
WO2015019125A1 (en) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Molecular targets for the treatment of wounds, in particular chronic wounds
US11596642B2 (en) 2016-05-25 2023-03-07 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
KR20200104298A (ko) 2017-11-22 2020-09-03 인바이오모션 에스.엘. c-MAF 상태에 기반한 유방암의 요법 치료

Also Published As

Publication number Publication date
BR0313199A (pt) 2005-06-21
IL166439A (en) 2009-12-24
MXPA05000387A (es) 2005-03-23
IL166439A0 (en) 2006-01-15
US7019028B2 (en) 2006-03-28
DE50302084D1 (de) 2006-02-02
EP1529040B1 (de) 2005-12-28
AU2003250099B2 (en) 2008-12-18
DE10235624A1 (de) 2004-02-19
JP2006503006A (ja) 2006-01-26
ES2254980T3 (es) 2006-06-16
ATE314359T1 (de) 2006-01-15
CA2493483A1 (en) 2004-02-19
US20040138313A1 (en) 2004-07-15
AU2003250099A1 (en) 2004-02-25
CA2493483C (en) 2011-09-20
JP4598523B2 (ja) 2010-12-15
EP1529040A1 (de) 2005-05-11
WO2004014888A1 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
MY139461A (en) Condensed furan compounds
DE60130771D1 (de) Substituierte heterocyclische amide
CR10499A (es) Profarmaco de compuesto de cinamida
MX2009004910A (es) Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo.
TW200642683A (en) Heterocyclic compound
PT934928E (pt) Derivados de amina ciclica
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
TW200637559A (en) 3-propenylcefem derivative
DK1529040T3 (da) Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma
JO2413B1 (en) Benzoxazine derivatives and their use
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
MY136824A (en) Substituted benzoxazinones and uses thereof
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
MY137964A (en) Benzofuran derivative
MXPA05012096A (es) Derivados de amina ciclica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
TW200732334A (en) A 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
IL141114A0 (en) NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS
DE602004011064D1 (en) Antitrombotische aether